Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hurley Ariel
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 8-K: Current report
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Rossi Christina
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director Albers Jeffrey W.
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 8-K: Current report
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Hurley Ariel
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Haviland Kate
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Officer Rossi Christina
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 4: Statement of changes in beneficial ownership of securities-Director COATS LONNEL
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | 144: Notice of proposed sale of securities pursuant to Rule 144
Blueprint Medicines | SC 13G/A: Statement of acquisition of beneficial ownership by individuals (Amendment)-T. ROWE PRICE ASSOCIATES, INC.(8.5%)